LGND Gross Profit Growth
Ligand Pharmaceuticals Inc · Gross Profit Growth
LGND Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported74.12%period ending
LGND TTM Gross Profit YoY % (339.47% → 74.12%)
Year-over-year change
High-resolution chart · PNG
LGND gross profit growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Gross Profit Growth |
|---|---|
| 74.1206% | |
| 53.2344% | |
| 67.5645% | |
| 51.4303% | |
| 24.0665% | |
| 75.882% | |
| 29.2104% | |
| 42.8453% | |
| 14.8357% | |
| -21.8625% | |
| 0.5813% | |
| -43.0321% | |
| -37.0664% | |
| -35.6653% | |
| -44.1372% | |
| -17.6665% | |
| -5.8334% | |
| 14.4729% | |
| 37.7929% | |
| 73.2028% | |
| 78.7697% | |
| 78.4685% | |
| 43.2047% | |
| -12.5897% | |
| -33.1594% | |
| -57.3677% | |
| -55.5578% | |
| -40.7673% | |
| -27.2097% | |
| 41.4337% | |
| 80.5856% | |
| 93.9598% | |
| 100.1251% | |
| 56.4871% | |
| 31.267% | |
| 38.3106% | |
| 32.8463% | |
| 27.5206% | |
| 56.4224% | |
| 36.4684% | |
| 36.2898% | |
| 46.6359% | |
| 19.3188% | |
| 30.0385% | |
| 32.0467% | |
| 21.1167% | |
| 28.1238% | |
| 21.1486% | |
| 28.7817% | |
| 37.4422% | |
| 55.6159% | |
| 50.3326% | |
| 36.1332% | |
| 22.2381% | |
| 10.5862% | |
| 50.4096% | |
| 27.4471% | |
| 30.0033% | |
| 6.7508% | |
| -62.7351% | |
| -37.7769% | |
| -40.8665% | |
| -39.5563% | |
| 120.67% | |
| -2.9596% | |
| 11.0275% | |
| 42.5664% | |
| 6.8757% | |
| 65.8193% | |
| 82.0054% | |
| 111.8427% | |
| -41.5037% | |
| -65.5851% | |
| -82.032% | |
| -90.6943% | |
| -76.5795% | |
| -60.2391% | |
| -34.8974% | |
| 2.9505% | |
| 25.1276% | |
| 20.9567% | |
| 23.0189% | |
| 8.7957% | |
| -17.1678% | |
| -2.7273% | |
| 0.8534% | |
| 12.9526% | |
| 76.9133% | |
| 63.9386% | |
| 66.8342% | |
| 43.4755% | |
| 13.1849% | |
| 15.4155% | |
| 4.0986% | |
| 18.7779% | |
| 40.6722% | |
| 36.923% | |
| 46.1028% | |
| 38.2354% | |
| 8.5715% |